Astellas Pharma €800 million acquisition of Ogeda

7/4/2017
Private acquisition

€ 800 million

$ 875.744 million

Completed

7/4/2017


Overview:

  • Astellas Pharma has completed the €800 million acquisition of Ogeda.
  • The target is a privately owned Belgian drug discovery company.
  • The buyer is Japanese pharmaceutical company that is part of the Mitsubishi UFJ Financial Group.
  • This deal is the latest in a string of recent international purchases by the company, including the $379 million acquisition of Massachusetts-based Ocata Therapeutics in February 2016 and the €422 million acquisition of Ganymed Pharmaceuticals, which is based in Mainz, Germany.

Jon Moore - Journalist

Jurisdiction:

Belgium

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

Belgium

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Astellas Pharma (Acquirer)